|
OPINION
Editorial
Risk-sharing plan for MDs is bad policy
Polly Thompson
Éditorial
Le régime de récompense pour les médecins laisse à désirer
Guest Editorial
Rofecoxib announcement could have long-term implications
Alan J. Forster
Commentary
OTC statins: opportunity or threat?
William Semchuk, Jeffrey G. Taylor, Ross T. Tsuyuki
Letters to the Editor
Bev Harris, Charles D. Bayliff, Ron Marcinkoski, Jack Hoffman
PULSE - News This Month
Proposed deal on Rx costs garners mixed reviews
Nova Scotia boosts Rx monitoring body
Workplace support for asthma management
17% cut from NIHB hurts BC pharmacists
Sales curb a possibility to fight crystal meth
Medications in the news
Drug supply threatened, claims coalition
FEATURES
Spotlight on Research
Pharmacists deliver anticoagulation therapy
Tammy Bungard
Practice Spotlight
Patient tool in combination antiplatelet Rx
Margaret Ackman, Wendy Gordon, Heather Kertland, Don Kuntz, Jennifer Pickering, and Ann Thompson
Pharmacists break ground at asthma camp
Shannan L. Neubauer, Charity D. Evans, and Sarah S. Jacques
Are we ready for prescriptive authority? Lessons from the self-care example
Roy Dobson, Jeffrey G. Taylor, Larry D. Lynd
DEPARTMENTS
Product update
Denis Bélanger
Focus on Patient Care
Non-prescription painkillers and chronic liver disease
Ellen Fan and Scott Gavura
Focus on Error Prevention
Consign handwritten prescriptions to the past
Ian Stewart
Alternative Medicine
Blue cohosh toxic during pregnancy
Mario Bédard
Journal Club
Rofecoxib data on CV effects were troubling for years
Susan Pierce
SPONSORED COLUMNS
Dialogue on Diabetes
Taking the fear out of insulin
Don Rusnak
Ask Your Pharmacist
Diagnosing osteoporosis
Sherry Hertz
Treating osteoporosis
Sherry Hertz
close window
|
